Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis

Journal of Hepatology

Volumn 43, Issue 1, 2005, Pages 142-148

  Sen, Sambit ^a   Mookerjee, Rajeshwar P ^a   Cheshire, Lisa M ^a   Davies, Nathan A ^a   Williams, Roger ^a   Jalan, Rajiv ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Inflammation; Liver support; Portal hypertension

Indexed keywords

ALBUMIN;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; DIALYSIS MEMBRANE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMODYNAMICS; HEMOFILTRATION; HEPATIC ENCEPHALOPATHY; HEPATIC VEIN; HUMAN; KIDNEY FAILURE; MALE; MULTIPLE ORGAN FAILURE; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL;

ADULT; ALBUMINS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; FEMALE; HEMODYNAMIC PROCESSES; HEMOFILTRATION; HEPATIC ENCEPHALOPATHY; HEPATIC VEINS; HEPATITIS, ALCOHOLIC; HUMANS; HYPERTENSION, PORTAL; KIDNEY FAILURE; LIVER CIRCULATION; MALE; MIDDLE AGED; PORTAL SYSTEM; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VENOUS PRESSURE;

EID: 20444413736     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.01.032     Document Type: Article

References (33)

1. J. Bosch, and J.C. Garcia-Pagan Prevention of variceal rebleeding Lancet 361 2003 952 954
2. K.M. Comar, and A.J. Sanyal Portal hypertensive bleeding Gastroenterol Clin North Am 32 2003 1079 1105
3. T. Poynard, C. Degott, C. Munoz, and D. Lebrec Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosis. Effect of acute alcoholic hepatitis on portal hypertension Dig Dis Sci 32 1987 337 343
4. R.P. Mookerjee, S. Sen, N.A. Davies, S.J. Hodges, R. Williams, and R. Jalan Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis Gut 52 2003 1182 1187
5. A.S. Austin, Y.R. Mahida, D. Clarke, S.D. Ryder, and J.G. Freeman A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis Aliment Pharmacol Ther 19 2004 79 88
6. U. Heemann, U. Treichel, J. Loock, T. Philipp, G. Gerken, and M. Malago Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study Hepatology 36 2002 949 958
7. M.V. Catalina, J. Barrio, F. Anaya, M. Salcedo, D. Rincon, and G. Clemente Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure Liver Int 23 Suppl 3 2003 39 43
8. H.O. Conn, C.M. Leevy, Z.R. Vlahcevic, J.B. Rodgers, W.C. Maddrey, and L. Seeff Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial Gastroenterology 72 1977 573 583
9. R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson, M.C. Pietroni, and R. Williams Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
10. W.C. Maddrey, J.K. Boitnott, M.S. Bedine, F.L. Weber Jr, E. Mezey, and R.I. White Jr Corticosteroid therapy of alcoholic hepatitis Gastroenterology 75 1978 193 199
11. J. Stange, W. Ramlow, S. Mitzner, R. Schmidt, and H. Klinkmann Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins Artif Organs 17 1993 809 813
12. J. Stange, and S. Mitzner A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver Int J Artif Organs 19 1996 677 691
13. E. Christensen, and C. Gluud Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables Gut 37 1995 113 118
14. T.F. Imperiale, and A.J. McCullough Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials Ann Intern Med 113 1990 299 307
15. R.J. Groszmann, J. Bosch, N.D. Grace, H.O. Conn, G. Garcia-Tsao, and M. Navasa Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage Gastroenterology 99 1990 1401 1407
16. F. Feu, J.C. Garcia-Pagan, J. Bosch, A. Luca, J. Teres, and A. Escorsell Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis Lancet 346 1995 1056 1059
17. T.K. Gupta, L. Chen, and R.J. Groszmann Pathophysiology of portal hypertension Baillieres Clin Gastroenterol 11 1997 203 219
18. P. Sorkine, R. Ben Abraham, O. Szold, P. Biderman, A. Kidron, and H. Merchav Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure Crit Care Med 29 2001 1332 1336
19. S.R. Mitzner, S. Klammt, P. Peszynski, H. Hickstein, G. Korten, and J. Stange Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system Ther Apher 5 2001 417 422
20. L.E. Schmidt, V.R. Sorensen, L.B. Svendsen, B.A. Hansen, and F.S. Larsen Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure Liver Transpl 7 2001 1034 1039
21. S.R. Mitzner, J. Stange, S. Klammt, T. Risler, C.M. Erley, and B.D. Bader Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial Liver Transpl 6 2000 277 286
22. P. Vallance, and S. Moncada Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 337 1991 776 778
23. C. Steiner, A. Zinggrebe, and A. Viertler Experiences with MARS therapy in liver disease: analysis of 385 patients of the International MARS Registry Hepatology 38 2003 239A
24. Sen S, Davies NA, Mookerjee RP, Cheshire LM, Hodges SJ, Williams R, et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomised controlled study. Liver Transplant 2004;10:1109-1119.
25. A.J. Stanley, R. Jalan, E.H. Forrest, D.N. Redhead, and P.C. Hayes Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients [see comments] Gut 39 1996 479 485
26. A.J. Stanley, D.N. Redhead, and P.C. Hayes Review article: update on the role of transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of complications of portal hypertension Aliment Pharmacol Ther 11 1997 261 272
27. R. Jalan, H.F. Lui, D.N. Redhead, and P.C. Hayes TIPSS 10 years on Gut 46 2000 578 581
28. R. Jalan, K. Dabos, D.N. Redhead, A. Lee, and P.C. Hayes Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage J Hepatol 27 1997 928 933
29. R. Jalan, K.I. Bzeizi, D. Tripathi, H.F. Lui, D.N. Redhead, and P.C. Hayes Impact of transjugular intrahepatic portosystemic stent-shunt for secondary prophylaxis of oesophageal variceal haemorrhage: a single-centre study over an 11-year period Eur J Gastroenterol Hepatol 14 2002 615 626
30. R.F. Silva, P.C. Arroyo Jr, W.J. Duca, A.A. Silva, L.F. Reis, and C.M. Cabral Complications following transjugular intrahepatic portosystemic shunt: a retrospective analysis Transplant Proc 36 2004 926 928
31. R. Jalan, T.G. John, D.N. Redhead, O.J. Garden, K.J. Simpson, and N.D. Finlayson A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage Am J Gastroenterol 90 1995 1932 1937
32. T.N. Chau, D. Patch, Y.W. Chan, A. Nagral, R. Dick, and A.K. Burroughs "Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding Gastroenterology 114 1998 981 987
33. S. Sen, C. Steiner, R. Williams, and R. Jalan Artificial liver support: overview of registry and controlled clinical trials V. Arroyo X. Forns J.C. Garcia-Pagan J. Rodes Progress in the treatment of liver diseases 2003 Ars Medica Barcelona 429 435